A substantial advancement in blood sugar treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://pennyfemi128356.gynoblog.com/39650323/groundbreaking-approach-tirzepatide-dose-for-glucose-regulation